View Item 

Show simple item record

In utero and peripartum antiretroviral exposure as predictor of cognition in 6‐ to 10‐year‐old HIV‐exposed Ugandan children – a prospective cohort study
dc.contributor.authorEzeamama, AE
dc.contributor.authorZalwango, SK
dc.contributor.authorSikorskii, A
dc.contributor.authorTuke, R
dc.contributor.authorMusoke, PM
dc.contributor.authorGiordani, B
dc.contributor.authorBoivin, MJ
dc.date.accessioned2021-08-03T18:14:43Z
dc.date.available2022-09-03 14:14:41en
dc.date.available2021-08-03T18:14:43Z
dc.date.issued2021-08
dc.identifier.citationEzeamama, AE; Zalwango, SK; Sikorskii, A; Tuke, R; Musoke, PM; Giordani, B; Boivin, MJ (2021). "In utero and peripartum antiretroviral exposure as predictor of cognition in 6‐ to 10‐year‐old HIV‐exposed Ugandan children – a prospective cohort study." HIV Medicine (7): 592-604.
dc.identifier.issn1464-2662
dc.identifier.issn1468-1293
dc.identifier.urihttps://hdl.handle.net/2027.42/168455
dc.publisherWiley Periodicals, Inc.
dc.publisherPsychological Assessment Resources
dc.subject.otherHIV‐exposed children
dc.subject.otherexecutive function
dc.subject.othercognitive function
dc.subject.othersocioemotional adjustment
dc.subject.othermaternal ART
dc.subject.otherin utero ART
dc.titleIn utero and peripartum antiretroviral exposure as predictor of cognition in 6‐ to 10‐year‐old HIV‐exposed Ugandan children – a prospective cohort study
dc.typeArticle
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelMicrobiology and Immunology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168455/1/hiv13094_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/168455/2/hiv13094.pdf
dc.identifier.doi10.1111/hiv.13094
dc.identifier.sourceHIV Medicine
dc.identifier.citedreferenceYakah W, Fenton JI, Sikorskii A et al. Serum Vitamin D is differentially associated with socioemotional adjustment in early school‐aged Ugandan children according to perinatal HIV status and In utero/peripartum antiretroviral exposure history. Nutrients 2019; 11 ( 7 ): 1570.
dc.identifier.citedreferenceJones HE, Schooling CM. Let’s Require the "T‐Word". Am J Public Health 2018; 108 ( 5 ): 624.
dc.identifier.citedreferencePazzagli L, Stuart EA, Hernan M, Schneeweiss S. Causal inference in pharmacoepidemiology. Pharmacoepidem Dr S 2019; 28: 414 – 415.
dc.identifier.citedreferenceGlass TA, Goodman SN, Hernan MA, Samet JM. Causal inference in public health. Annu Rev Publ Health 2013; 34: 61 – 75.
dc.identifier.citedreferenceHernan MA. Beyond exchangeability: The other conditions for causal inference in medical research. Stat Methods Med Res 2012; 21 ( 1 ): 3 – 5.
dc.identifier.citedreferenceNorman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health‐related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41 ( 5 ): 582 – 592.
dc.identifier.citedreferenceErder MH, Santanello N, Hays RD. Assessing the clinical significance of patient‐reported outcomes: examples drawn from a recent meeting of the drug information association (DIA). Clin Ther 2003; 25: D12 – D13.
dc.identifier.citedreferenceUNAIDS. Global report: UNAIDS Report on the Global AIDS Epidemic 2008. 2008. Available at https://www.unaids.org/sites/default/files/media_asset/jc1510_2008globalreport_en_0.pdf.
dc.identifier.citedreferenceSmith ML, Puka K, Sehra R, Read SE, Bitnun A. Longitudinal development of cognitive, visuomotor and adaptive behavior skills in HIV uninfected children, aged 3–5 years of age, exposed pre‐ and perinatally to anti‐retroviral medications. AIDS Care 2017; 29 ( 10 ): 1302 – 1308.
dc.identifier.citedreferenceJain R, Ezeamama AE, Sikorskii A et al. Serum n‐6 Fatty Acids are Positively Associated with Growth in 6‐to‐10‐Year Old Ugandan Children Regardless of HIV Status‐A Cross‐Sectional Study. Nutrients. 2019; 11 ( 6 ): 1268.
dc.identifier.citedreferenceEzeamama AE, Zalwango SK, Tuke R et al. Toxic Stress and Quality of Life in Early School‐Aged Ugandan Children With and Without Perinatal Human Immunodeficiency Virus Infection. New Dir Child Adolesc Dev 2020; 2020 ( 171 ): 15 – 38.
dc.identifier.citedreferenceTuke R, Sikorskii A, Zalwango SK et al. Psychosocial Adjustment in Ugandan Children: Coping With Human Immunodeficiency Virus Exposure, Lifetime Adversity, and Importance of Social Support. New Dir Child Adolesc Dev 2020; 2020 ( 171 ): 55 – 75.
dc.identifier.citedreferenceCulnane M, Fowler M, Lee SS et al. Lack of long‐term effects of in utero exposure to zidovudine among uninfected children born to HIV‐infected women. Pediatric AIDS Clinical Trials Group Protocol 219/076 Teams. JAMA 1999; 281 ( 2 ): 151 – 157.
dc.identifier.citedreferenceCassidy AR, Williams PL, Leidner J et al. In Utero Efavirenz Exposure and Neurodevelopmental Outcomes in HIV‐exposed Uninfected Children in Botswana. Pediatr Infect Dis J 2019; 38 ( 8 ): 828 – 834.
dc.identifier.citedreferenceCarneiro M, Sanchez A, Maneiro P, Angelosante W, Perez C, Vallee M. Vertical HIV‐1 transmission: prophylaxis and paediatric follow‐up. Placenta 2001;22 Suppl A:S13–18.
dc.identifier.citedreferenceApostolova N, Blas‐Garcia A, Esplugues JV. Mitochondrial interference by anti‐HIV drugs: mechanisms beyond Pol‐gamma inhibition. Trends Pharmacol Sci 2011; 32 ( 12 ): 715 – 725.
dc.identifier.citedreferenceBrogly SB, Ylitalo N, Mofenson LM et al. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV‐uninfected children. AIDS 2007; 21 ( 8 ): 929 – 938.
dc.identifier.citedreferenceChan SS, Santos JH, Meyer JN et al. Mitochondrial toxicity in hearts of CD‐1 mice following perinatal exposure to AZT, 3TC, or AZT/3TC in combination. Environ Mol Mutagen 2007; 48 ( 3–4 ): 190 – 200.
dc.identifier.citedreferenceVenerosi A, Valanzano A, Alleva E, Calamandrei G. Prenatal exposure to anti‐HIV drugs: neurobehavioral effects of zidovudine (AZT) + lamivudine (3TC) treatment in mice. Teratology 2001; 63 ( 1 ): 26 – 37.
dc.identifier.citedreferenceBrittain K, Myer L, Phillips N et al. Behavioural health risks during early adolescence among perinatally HIV‐infected South African adolescents and same‐age, HIV‐uninfected peers. AIDS Care 2019; 31 ( 1 ): 131 – 140.
dc.identifier.citedreferencePiske M, Budd MA, Qiu AQ et al. Neurodevelopmental outcomes and in‐utero antiretroviral exposure in HIV‐exposed uninfected children. Aids 2018; 32 ( 17 ): 2583 – 2592.
dc.identifier.citedreferenceWebster KD, de Bruyn MM, Zalwango SK et al. Caregiver socioemotional health as a determinant of child well‐being in school‐aged and adolescent Ugandan children with and without perinatal HIV exposure. Trop Med Int Health 2019; 24 ( 5 ): 608 – 619.
dc.identifier.citedreferenceCarlson SM. Social origins of executive function development. New Dir Child Adolesc Dev 2009; 2009 ( 123 ): 87 – 98.
dc.identifier.citedreferenceCooper RP. Development of executive function: more than conscious reflection. Dev Sci 2009; 12 ( 1 ): pp. 19–20; discussion 24–15.
dc.identifier.citedreferenceBeauchamp MH, Anderson V. SOCIAL: An integrative framework for the development of social skills. Psychol Bull. 2010; 136 ( 1 ): 39 – 64.
dc.identifier.citedreferenceRichland LE, Burchinal MR. Early executive function predicts reasoning development. Psychol Sci 2013; 24 ( 1 ): 87 – 92.
dc.identifier.citedreferenceLopes PN, Nezlek JB, Extremera N et al. Emotion Regulation and the Quality of Social Interaction: Does the Ability to Evaluate Emotional Situations and Identify Effective Responses Matter? J Pers 2011; 79 ( 2 ): 429 – 467.
dc.identifier.citedreferenceRobertson FC, Holmes MJ, Cotton MF et al. Perinatal HIV Infection or Exposure Is Associated With Low N‐Acetylaspartate and Glutamate in Basal Ganglia at Age 9 but Not 7 Years. Front Hum Neurosci 2018; 12: 145.
dc.identifier.citedreferenceShrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979; 86 ( 2 ): 420 – 428.
dc.identifier.citedreferenceHamer RM. Compute six intraclass correlation measures. 2000; http://support.sas.com/kb/25/031.html. Accessed August 3, 2015.
dc.identifier.citedreferenceUNAIDS. UNAIDS DATA 2018. 2018.
dc.identifier.citedreferenceMcCormack SA, Best BM. Protecting the fetus against HIV infection: a systematic review of placental transfer of antiretrovirals. Clin Pharmacokinet. 2014; 53 ( 11 ): 989 – 1004.
dc.identifier.citedreferenceTraore H, Meda N, Nagot N et al. Determinants of low birth weight among newborns to HIV‐infected mothers not eligible for antiretroviral treatment in Africa. Rev Epidemiol Sante Publique. 2013; 61 ( 5 ): 413 – 420.
dc.identifier.citedreferenceWilliams PL, Hazra R, Van Dyke RB et al. Antiretroviral exposure during pregnancy and adverse outcomes in HIV‐exposed uninfected infants and children using a trigger‐based design. AIDS. 2016; 30 ( 1 ): 133 – 144.
dc.identifier.citedreferenceHernandez S, Catalan‐Garcia M, Moren C et al. Placental mitochondrial toxicity, oxidative stress, apoptosis, and adverse perinatal outcomes in HIV pregnancies under antiretroviral treatment containing zidovudine. J Acquir Immune Defic Syndr. 2017; 75 ( 4 ): e113 – e119.
dc.identifier.citedreferenceJao J, Powis KM, Kirmse B et al. Lower mitochondrial DNA and altered mitochondrial fuel metabolism in HIV‐exposed uninfected infants in Cameroon. AIDS. 2017; 31 ( 18 ): 2475 – 2481.
dc.identifier.citedreferenceNoguera‐Julian A, Moren C, Rovira N et al. Decreased mitochondrial function among healthy infants exposed to antiretrovirals during gestation, delivery and the neonatal period. Pediatr Infect Dis J. 2015; 34 ( 12 ): 1349 – 1354.
dc.identifier.citedreferencePoirier MC, Gibbons AT, Rugeles MT, Andre‐Schmutz I, Blanche S. Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy. Curr Opin Pediatr. 2015; 27 ( 2 ): 233 – 239.
dc.identifier.citedreferenceGill AJ, Kovacsics CE, Vance PJ, Collman RG, Kolson DL. Induction of heme oxygenase‐1 deficiency and associated glutamate‐mediated neurotoxicity is a highly conserved HIV phenotype of chronic macrophage infection that is resistant to antiretroviral therapy. J Virol 2015; 89 ( 20 ): 10656 – 10667.
dc.identifier.citedreferenceUnderwood J, Robertson KR, Winston A. Could antiretroviral neurotoxicity play a role in the pathogenesis of cognitive impairment in treated HIV disease? AIDS. 2015; 29 ( 3 ): 253 – 261.
dc.identifier.citedreferenceStevens J, Lyall H. Mother to child transmission of HIV: what works and how much is enough? J Infect. 2014; 69 ( Suppl 1 ): S56 – 62.
dc.identifier.citedreferenceCoelho AV, Tricarico PM, Celsi F, Crovella S. Antiretroviral treatment in HIV‐1‐positive mothers: neurological implications in virus‐free children. Int J Mol Sci. 2017; 18 ( 2 ): 423. https://doi.org/10.3390/ijms18020423
dc.identifier.citedreferenceNgoma MS, Hunter JA, Harper JA et al. Cognitive and language outcomes in HIV‐uninfected infants exposed to combined antiretroviral therapy in utero and through extended breast‐feeding. AIDS 2014; 28 ( Suppl 3 ): S323 – 330.
dc.identifier.citedreferenceDebeaudrap P, Bodeau‐Livinec F, Pasquier E et al. Neurodevelopmental outcomes in HIV‐infected and uninfected African children. AIDS 2018; 32 ( 18 ): 2749 – 2757.
dc.identifier.citedreferenceChaudhury S, Mayondi GK, Williams PL et al. In‐utero exposure to antiretrovirals and neurodevelopment among HIV‐exposed‐uninfected children in Botswana. AIDS 2018; 32 ( 9 ): 1173 – 1183.
dc.identifier.citedreferenceChi BH, Stringer JSA, Moodley D. Antiretroviral drug regimens to prevent mother‐to‐child transmission of HIV: a review of scientific, program, and policy advances for sub‐Saharan Africa. Curr HIV/AIDS Rep 2013; 10 ( 2 ): 124 – 133.
dc.identifier.citedreferenceMcHenry MS, McAteer CI, Oyungu E et al. Neurodevelopment in young children born to HIV‐infected mothers: a meta‐analysis. Pediatrics 2018; 141 ( 2 ).
dc.identifier.citedreferenceRice ML, Buchanan AL, Siberry GK et al. Language impairment in children perinatally infected with HIV compared to children who were HIV‐exposed and uninfected. J Develop Behav Pediat 2012; 33 ( 2 ): 112 – 123.
dc.identifier.citedreferenceNozyce ML, Huo Y, Williams PL et al. Safety of in utero and neonatal antiretroviral exposure: cognitive and academic outcomes in HIV‐exposed, uninfected children 5–13 years of age. Pediatr Infect Dis J 2014; 33 ( 11 ): 1128 – 1133.
dc.identifier.citedreferencePuthanakit T, Ananworanich J, Vonthanak S et al. Cognitive function and neurodevelopmental outcomes in HIV‐infected children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study. Pediatr Infect Dis J 2013; 32 ( 5 ): 501 – 508.
dc.identifier.citedreferenceTuke R, Sikorskii A, Zalwango SK et al. Psychosocial adjustment in Ugandan children: coping with human immunodeficiency virus exposure, lifetime adversity, and importance of social support. New Dir Child Adolesc Dev 2020; 2020 ( 171 ): 55 – 75.
dc.identifier.citedreferenceDiStefano C, Greer FW, Dowdy E. Examining the BASC‐3 BESS parent form‐preschool using rasch methodology. Assessment 2019; 26 ( 6 ): 1162 – 1175.
dc.identifier.citedreferenceGioia G, Isquith P, Guy S, Kenworthy L. BRIEF: Behavior Rating Inventory of Executive Function. Lutz, FL, Psychological Assessment Resources, 2000.
dc.identifier.citedreferenceEzeamama AE, Guwatudde D, Wang M et al. High perceived social standing is associated with better health in HIV‐infected Ugandan adults on highly active antiretroviral therapy. J Behav Med 2016; 39 ( 3 ): 453 – 464.
dc.identifier.citedreferenceJackson JB, Musoke P, Fleming T et al. Intrapartum and neonatal single‐dose nevirapine compared with zidovudine for prevention of mother‐to‐child transmission of HIV‐1 in Kampala, Uganda: 18‐month follow‐up of the HIVNET 012 randomised trial. Lancet 2003; 362 ( 9387 ): 859 – 868.
dc.identifier.citedreferenceCressey TR, Jourdain G, Lallemant MJ et al. Persistence of nevirapine exposure during the postpartum period after intrapartum single‐dose nevirapine in addition to zidovudine prophylaxis for the prevention of mother‐to‐child transmission of HIV‐1. J Acquir Immune Defic Syndr. 2005; 38 ( 3 ): 283 – 288.
dc.identifier.citedreferenceMmiro FA, Aizire J, Mwatha AK et al. Predictors of early and late mother‐to‐child transmission of HIV in a breastfeeding population: HIV Network for Prevention Trials 012 experience, Kampala. Uganda. J Acquir Immune Defic Syndr 2009; 52 ( 1 ): 32 – 39.
dc.identifier.citedreferencePalumbo P, Lindsey JC, Hughes MD et al. Antiretroviral treatment for children with peripartum nevirapine exposure. N Engl J Med 2010; 363 ( 16 ): 1510 – 1520.
dc.identifier.citedreferenceHudgens MG, Taha TE, Omer SB et al. Pooled individual data analysis of 5 randomized trials of infant nevirapine prophylaxis to prevent breast‐milk HIV‐1 transmission. Clin Infect Dis 2013; 56 ( 1 ): 131 – 139.
dc.identifier.citedreferenceFillekes Q, Kendall L, Kitaka S et al. Pharmacokinetics of zidovudine dosed twice daily according to World Health Organization weight bands in Ugandan HIV‐infected children. Pediatr Infect Dis J 2014; 33 ( 5 ): 495 – 498.
dc.identifier.citedreferenceNational Antitretroviral treatment and care guidelines for adults, adolescents and children. Kampala, Uganda, The Director General Health Services, 2008.
dc.identifier.citedreferenceAppendix II. Youth risk behavior surveillance system questionnaire. Public Health Rep. 1993; 108 ( Suppl 1 ): 60 – 66.
dc.identifier.citedreferenceBarkin JL, McKeever A, Lian B, Wisniewski SR. Correlates of postpartum maternal functioning in a low‐income obstetric population. J Am Psychiat Nurses 2017; 23 ( 2 ): 149 – 158.
dc.identifier.citedreferenceGlover DA, Garcia‐Aracena EF, Lester P, Rice E, Rothram‐Borus MJ. Stress Biomarkers as outcomes for HIV plus prevention: participation, feasibility and findings among HIV plus Latina and African American Mothers. Aids Behav 2010; 14 ( 2 ): 339 – 350.
dc.identifier.citedreferenceTibshirani R. Regression shrinkage and selection via the lasso: a retrospective. J R Stat Soc B 2011; 73: 273 – 282.
dc.identifier.citedreferenceHernan MA, Hernandez‐Diaz S, Werler MM, Mitchell AA. Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol 2002; 155 ( 2 ): 176 – 184.
dc.working.doiNOen
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
hiv13094_am.pdf
Size:
899.7KB
Format:
PDF
View/Open
Name:
hiv13094.pdf
Size:
489.7KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.